Laboratory of Systems Cancer Biology, The Rockefeller University, New York, NY, USA.
Department of Biochemistry and Biophysics, University of California, San Francisco, CA, USA.
Nat Cell Biol. 2022 Mar;24(3):307-315. doi: 10.1038/s41556-022-00856-5. Epub 2022 Mar 14.
Tumourigenesis and cancer progression require enhanced global protein translation. Such enhanced translation is caused by oncogenic and tumour-suppressive events that drive the synthesis and activity of translational machinery. Here we report the surprising observation that leucyl-tRNA synthetase (LARS) becomes repressed during mammary cell transformation and in human breast cancer. Monoallelic genetic deletion of LARS in mouse mammary glands enhanced breast cancer tumour formation and proliferation. LARS repression reduced the abundance of select leucine tRNA isoacceptors, leading to impaired leucine codon-dependent translation of growth suppressive genes, including epithelial membrane protein 3 (EMP3) and gamma-glutamyltransferase 5 (GGT5). Our findings uncover a tumour-suppressive tRNA synthetase and reveal that dynamic repression of a specific tRNA synthetase-along with its downstream cognate tRNAs-elicits a downstream codon-biased translational gene network response that enhances breast tumour formation and growth.
肿瘤发生和癌症进展需要增强的全局蛋白质翻译。这种增强的翻译是由致癌和肿瘤抑制事件引起的,这些事件驱动翻译机制的合成和活性。在这里,我们报告了一个令人惊讶的观察结果,即亮氨酰-tRNA 合成酶(LARS)在乳腺细胞转化和人类乳腺癌中受到抑制。LARS 在小鼠乳腺中的单等位基因遗传缺失增强了乳腺癌肿瘤的形成和增殖。LARS 的抑制降低了特定亮氨酸 tRNA 同工受体的丰度,导致生长抑制基因(包括上皮膜蛋白 3(EMP3)和γ-谷氨酰转移酶 5(GGT5))的亮氨酸密码子依赖性翻译受损。我们的发现揭示了一种肿瘤抑制性 tRNA 合成酶,并表明特定 tRNA 合成酶及其下游同源 tRNA 的动态抑制会引发下游密码子偏倚的翻译基因网络反应,从而增强乳腺肿瘤的形成和生长。